I-13 Eva Germovsek Mechanistic Modelling of Total Body CD4 T-cell Counts from Paediatric HIV Patients Undergoing Planned Treatment Interruption Wednesday 10:20-11:50 |
I-33 Rollo Hoare Modelling CD4 lymphocyte reconstitution following paediatric haematopoietic stem cell transplantation Wednesday 10:20-11:50 |
I-38 Esther Janssen Simulations of vancomycin exposure throughout childhood upon commonly used dosing guidelines: towards a model-based dosing regimen Wednesday 10:20-11:50 |
II-06 Jean Lavigne Modeling and simulation of dihydroartemisinin (DHA) after administration of Eurartesim® (piperaquine tetraphosphate/DHA) Wednesday 15:10-16:30 |
II-13 Olaf Lichtenberger Evaluation of tetrahydrobiopterin responsiveness in neonates with hyperphenylalaninemia Wednesday 15:10-16:30 |
II-17 Merran Macpherson PPK analysis of Rouvastatin in Children and Adolescents (ages 6 to <18 years of age) with Familial Hypercholesterolemia to Support Regulatory Approval Wednesday 15:10-16:30 |
II-20 Andreas Matthios Dosing recommendation for gabapentin in chronic paediatric pain Wednesday 15:10-16:30 |
II-21 Johanna Melin Population pharmacokinetic analysis of hydrocortisone in paediatric patients with adrenal insufficiency Wednesday 15:10-16:30 |
II-30 Hussain Mulla Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration. Wednesday 15:10-16:30 |
II-32 Flora Musuamba-Tshinanu Optimisation of tacrolimus-based immunosuppressive treatment in pediatric solid organ transplantation: A model-based approach. Wednesday 15:10-16:30 |
II-46 Sophie Peigné Paediatric PK predictions and population analysis Wednesday 15:10-16:30 |
II-51 Yulan Qi A Prospective Population Pharmacokinetic (PK) Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria (PKU) Wednesday 15:10-16:30 |
III-03 Rick Admiraal Population pharmacokinetic modeling of Thymoglobulin in children receiving allogeneic-hematopoietic cell transplantation (HCT): towards individualized dosing to improve survival Thursday 10:05-11:30 |
III-29 Elisa Calvier Use of semi-physiological covariate model for maturation of glucuronidation to scale from adults to children Thursday 10:05-11:30 |
IV-07 Stephan Schmidt Evaluation of changes in oral drug absorption in preterm neonates for BCS class I and II compounds Thursday 15:15-16:40 |
IV-34 Pyry Välitalo Evaluation of gentamicin and tobramycin dosing guidelines for neonates; towards model-based dosing Thursday 15:15-16:40 |
IV-38 Anne van Rongen Population pharmacokinetics of a single intravenous dose of midazolam in obese, overweight and non-obese adolescents Thursday 15:15-16:40 |
IV-43 Chenguang Wang Population pharmacokinetics of paracetamol across the human age-range from (pre)term neonates, infants, children to adults Thursday 15:15-16:40 |
IV-58 Morris Muliaditan Population Pharmacokinetic Meta-Analysis of the Antiretroviral Agent Lamivudine in HIV-Infected Children Thursday 15:15-16:40 |
IV-59 Oscar Della Pasqua Population Pharmacokinetic Meta-Analysis of the Antiretroviral Agent Abacavir in HIV-Infected Children Thursday 15:15-16:40 |